EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2023-03-02 haalibing 来自江苏省

sci收录吗

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

摘要一般有什么要求？

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

我是写那种格式的摘要比较好？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2021-12-09 ms1000001057097466

审稿速度:2.0 | 投稿命中率:50.0
经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？

58 0

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2021-04-12 ms3000000713940731

审稿速度:1.0 | 投稿命中率:95.0
经验分享：哈哈哈

75 0

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2020-09-22 甄惜2627

修稿时让提两个问题并给出答案是什么意思

115 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2020-03-31 145b138dm45暂无昵称

唉，病例报告明确说不接受了

112 0

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2019-09-05 starmann

这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表:
这个杂志跟Journal of vascular surgery 哪个命中率高？

lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？

189 0

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2019-03-20 ghqngys

提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。

183 0

[GetPortalCommentsPageByObjectIdResponse(id=2117254, encodeId=3eca211e25487, content=sci收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80eb3071480, createdName=haalibing, createdTime=Thu Mar 02 16:37:40 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1090340, encodeId=50c21090340f4, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090339, encodeId=792e10903392d, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078330, encodeId=4d6710e833073, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑和审稿人都很友好，但我被接收已经将近40天了，为什么还没收到校稿邮件呢？大家都是什么时候收到校稿邮件的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=db725496828, createdName=ms1000001057097466, createdTime=Thu Dec 09 08:48:34 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956233, encodeId=7980956233ca, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d355479700, createdName=ms3000000713940731, createdTime=Mon Apr 12 18:00:52 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887502, encodeId=80c988e50299, content=修稿时让提两个问题并给出答案是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Tue Sep 22 21:55:35 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587845, encodeId=b5b558e84530, content=唉，病例报告明确说不接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575857, encodeId=1a7e5e58575f, content=这个高一些，更友好lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=lollipop3 2018-12-05 10:03:00 发表: 这个杂志跟Journal of vascular surgery 哪个命中率高？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB00bdial8SFZdQ2URWw7LRNDRMY2TRQG8HibNuXsnOibzyITBEvcRruEssalL5CSmXbZwNYa41jm4eQ/0, createdBy=a8011926271, createdName=starmann, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568354, encodeId=dad4568354d4, content=提交了一篇主动脉介入的文章，5天后可能是被编辑直接拒稿，但是给了几个意见，说如果能够把他提的问题很好的说明的话可以重新投稿，重新开始同行评议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epj2iawSVqELZSP3LRkSKNllmibrhiaEjxQytibxHz5GnkHItUiboyEc9wtt0B7Rt2pIc2utc5CjV4kNfg/132, createdBy=4e202371591, createdName=ghqngys, createdTime=Wed Mar 20 15:34:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564057, encodeId=594456405e21, content=这个杂志跟Journal of vascular surgery 哪个命中率高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/04/054c2c0fd2ddc574d327ba6a4f9957bb.jpg, createdBy=5ffa2345199, createdName=lollipop3, createdTime=Wed Dec 05 10:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=)]

2018-12-05 lollipop3

这个杂志跟Journal of vascular surgery 哪个命中率高？

213 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务